EAVI2020 Partner Focused Stories: University of Melbourne
Prof Stephen Kent and Prof Robin Shattock outside the entrance to St Mary’s Hospital, Imperial College London
Established in 1853, the University of Melbourne (UOM) is an internationally recognised institution that makes distinctive contributions to society in research, learning and teaching and engagement. Ranked as one of the leading universities in the world, it is currently placed at number 1 in Australia and number 32 in the world (Times Higher Education World University Rankings 2018).
The EAVI2020 grant has given the Australian researchers involved in our EU funded project an opportunity to engage in a forum that enables free exchange of cutting edge ideas for vaccine design, provides a pipeline for the rapid pre-clinical and clearly phase clinical testing of their most promising constructs and allows access to expertise for the in-depth study of the immune responses these vaccines induce.
Prof. Stephen Kent, Principal Investigator for UOM, will be visiting several EAVI2020 Partners over the coming summer months. Most recently, he spent time with Prof. Robin Shattock of Imperial College London and will go on to visit Partners INSERM, CEA, AMC, UKER, UJF and KI. Stephen will also be attending the ‘One Health’ conference in Paris, the ‘IAS 2018’ conference in Amsterdam and an ‘NIH workshop on HIV antibody immunity’ in Washington DC, as well as visiting another HIV research group in Aarhus Denmark.
The Consortium as a whole enjoys and benefits greatly from its shared collaborative efforts, we look forward to the continued partnership with Stephen and his team.